|
INPP5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.997780E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.045200E-01 |
| Normal-vs-Stage2 |
9.933800E-01 |
| Normal-vs-Stage3 |
8.534600E-01 |
| Normal-vs-Stage4 |
2.541200E-01 |
| Stage1-vs-Stage2 |
2.833800E-01 |
| Stage1-vs-Stage3 |
2.192000E-01 |
| Stage1-vs-Stage4 |
8.014800E-01 |
| Stage2-vs-Stage3 |
8.983400E-01 |
| Stage2-vs-Stage4 |
3.434200E-01 |
| Stage3-vs-Stage4 |
3.254200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.759600E-01 |
| Normal-vs-AfricanAmerican |
2.530800E-01 |
| Normal-vs-Asian |
1.703620E-01 |
| Caucasian-vs-AfricanAmerican |
8.199800E-01 |
| Caucasian-vs-Asian |
6.424400E-01 |
| AfricanAmerican-vs-Asian |
9.042200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.345700E-02 |
| Normal-vs-Female |
4.242200E-01 |
| Male-vs-Female |
1.489590E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.137830E-01 |
| Normal-vs-Age(41-60Yrs) |
5.178000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.923200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.765600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.410200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.657000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.474800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.882800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.184400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.589600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.366200E-04 |
| Classical-VS-Follicular |
1.161760E-03 |
| Classical-VS-Other |
4.555400E-01 |
| Classical-VS-Normal |
9.235400E-03 |
| Tall-VS-Follicular |
5.082800E-01 |
| Tall-VS-Other |
4.278800E-01 |
| Tall-VS-Normal |
1.162040E-01 |
| Follicular-VS-Other |
7.399800E-01 |
| Follicular-VS-Normal |
4.053800E-01 |
| Other-VS-Normal |
9.758200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.107400E-01 |
| Normal-vs-N1 |
8.171800E-01 |
| N0-vs-N1 |
8.146200E-01 |
|
|
